retatrutide dosing in clinical trials for weight loss: Study shows 30% body weight loss Phase III retatrutide study demonstrates

Obesity Pillars

Inconsistencies between documents trigger additional scrutiny

SGLT2 inhibitors may improve metabolic profiles in selected non-pregnant patients, but any such use must remain strictly outside pregnancy, under reliable contraception, and with guideline-consistent discontinuation before conception attempts because of urogenital adverse effects and contraindications during pregnancy (155, 156)

Giugliano D, Scappaticcio L, Longo M et al

They now cost about Rs 1,0002,500 a month, and there's growing evidence pointing to benefits well beyond weight loss, including cardiovascular, metabolic, and liver health

The blood test, delivered every four months, tracks 17 biomarkers including HbA1c, ApoB, hs-CRP, and hormonal markers such as DHEA-S, testosterone, and estradiol